Treating sepsis

Affiliations

Comment

Richard P Wenzel. N Engl J Med. 2002.

. 2002 Sep 26;347(13):966-7.

doi: 10.1056/NEJMp020096.

No abstract available

Comment on

An economic evaluation of activated protein C treatment for severe sepsis.
Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. Manns BJ, et al. N Engl J Med. 2002 Sep 26;347(13):993-1000. doi: 10.1056/NEJMsa020969. N Engl J Med. 2002. PMID: 12324556
Risks and benefits of activated protein C treatment for severe sepsis.
Warren HS, Suffredini AF, Eichacker PQ, Munford RS. Warren HS, et al. N Engl J Med. 2002 Sep 26;347(13):1027-30. doi: 10.1056/NEJMsb020574. N Engl J Med. 2002. PMID: 12324562 No abstract available.
Assessing the use of activated protein C in the treatment of severe sepsis.
Siegel JP. Siegel JP. N Engl J Med. 2002 Sep 26;347(13):1030-4. doi: 10.1056/NEJMsb021512. N Engl J Med. 2002. PMID: 12324563 No abstract available.
Activated protein C for severe sepsis.
Ely EW, Bernard GR, Vincent JL. Ely EW, et al. N Engl J Med. 2002 Sep 26;347(13):1035-6. doi: 10.1056/NEJM200209263471315. N Engl J Med. 2002. PMID: 12324564 No abstract available.